Henry Heinsohn is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of biopharmaceuticals, particularly in the stabilization of bacterial extracts for protein synthesis. With a total of 4 patents to his name, Heinsohn's work is paving the way for advancements in cell-free protein synthesis technologies.

Latest Patents

One of Heinsohn's latest patents focuses on formulations for drying bacterial cell extracts. This invention provides an improved method of stabilizing freeze-dried bacterial extracts using a carbohydrate lyoprotectant. The goal is to ensure that these extracts can be effectively utilized in cell-free protein synthesis. Additionally, the formulations are designed to retain at least about 70% protein synthesis activity when stored at room temperature, compared to undried frozen bacterial extracts.

Career Highlights

Heinsohn's career is marked by his role at Sutro Biopharma, Inc., where he has been instrumental in developing innovative solutions for the biopharmaceutical industry. His expertise in bacterial extract stabilization has positioned him as a key player in advancing protein synthesis technologies.

Collaborations

Heinsohn has collaborated with notable colleagues, including Martin Chandler and Kirk Hayenga. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Henry Heinsohn's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his commitment to advancing technology in protein synthesis. His work continues to influence the industry and pave the way for future innovations.